In contrast, De Sanctis et al. reported no variations in IL-8 serum level at 4 weeks after radiotherapy when compared to baseline [42], whereas Muraro et al. reported a lower IL-8 level in breast cancer patients compared to controls at baseline and a significant increase 1 month after SBRT [43]. Here, CXCL8 is linked to breast cancer.